Showing results (241-250 of 1,085) with videos related to

Sort By:
Pageof 109
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantationGiuseppe Musumeci, Roberta Rossini, Corrado Lettieri, et al.
Thrombosis and Haemostasis|February 14, 2019
Aspirin-Dependent Effects on Purinergic P2Y1 Receptor ExpressionIsabella Massimi, Laura Alemanno, Maria Luisa Guarino, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future ApplicationsAlessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
JACC. Cardiovascular Interventions|March 7, 2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE ScoreDominick J Angiolillo, Davide Capodanno, Nicolas Danchin, et al.
Thrombosis Research|November 18, 2008
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patientsDominick J Angiolillo, Piera Capranzano, Bhaloo Desai, et al.
BMC Medical Genetics|September 7, 2007
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery diseaseUgo Cavallari, Elisabetta Trabetti, Giovanni Malerba, et al.
Journal of Cardiovascular Development and Disease|May 26, 2026
In Hospital Assessment and Management of High Bleeding Risk in Patients with ST-Elevation Myocardial Infarction (STEMI)Sanghoon Kim, Alberto Piserra-López, Salvatore Giordano, et al.
Circulation|February 21, 2002
Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive proteinElisabetta Rossi, Luigi M Biasucci, Franco Citterio, et al.
JACC. Cardiovascular Interventions|August 13, 2025
Aspirin or P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Daniele Giacoppo, Giovanni Occhipinti, et al.
Pageof 109